Search

everythinglearnresearchcommunity

for

Search:↓

XEDAR triggers a specific signaling pathway in cells.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Two siblings with a rare type of rickets and hair loss had low vitamin D levels, which is not typical for their condition.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Clascoterone may be a promising treatment for hair loss.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Laminin-511 is crucial for early hair growth and maintaining important hair development signals.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Follicle Stimulating Hormone is important for fertility.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Cantú syndrome is caused by mutations in the ABCC9 gene.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Different fish use the same genes to regrow teeth.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.